Study Highlights High Opioid Prescription Rates Among Arkansas Women of Reproductive Age

Why it matters locally: This national study on opioid prescriptions among women of reproductive age (15-44) is particularly relevant to Arkansas due to the state's existing challenges with opioid addiction and healthcare access. The study's finding that a significant portion of women in this demographic receive opioid prescriptions, especially those enrolled in Medicaid (over one-third), raises concerns for Arkansas, given the state's high Medicaid enrollment rates and the potential impact on maternal and infant health outcomes. The high rates could contribute to Arkansas's existing challenges regarding neonatal abstinence syndrome (NAS) and other complications related to opioid use during pregnancy. The study focuses on Medicaid data which is particularly helpful, as the state's lower average household income means a greater percentage of Arkansans rely on Medicaid for healthcare. Furthermore, the high prescription rates can strain the state's healthcare system, which is responsible for treating opioid addiction. Businesses in Arkansas face challenges related to workforce participation and productivity due to opioid-related issues, and the study findings could warrant additional resources or policy focus into prevention and treatment initiatives aimed at women of reproductive age. This study serves as a valuable basis for Arkansas policymakers and healthcare professionals to re-evaluate prescription practices and explore ways to mitigate potential harm.

---

A report in the Morbidity and Mortality Weekly Report (MMWR) has examined the prevalence of opioid painkiller prescriptions among women of reproductive age in the United States between 2008 and 2012. The Centers for Disease Control and Prevention (CDC) released the report. The study focused on women aged 15-44 who were enrolled in either Medicaid or had private insurance. Researchers analyzed prescription data to determine the percentage of women filling at least one opioid prescription each year during the five-year period. The findings indicated that a significant portion of women in this demographic received opioid prescriptions. The report stated that over one-third of reproductive-aged women enrolled in Medicaid filled an opioid painkiller prescription annually. Among women with private insurance, the rate was over one-quarter. The report does not offer reasons for the prescription rates, but it provides a quantification of opioid use among women during their reproductive years. Further research would need to be done to determine the conditions for which the opioids were prescribed, the dosages prescribed, and the long-term outcomes for the respective patients. The scope of the study was limited to the period from 2008 to 2012. Data on more recent trends in opioid prescriptions for this population would provide a more current understanding of the issue.